Shilpa Pharma Lifesciences reçoit la médaille d’or EcoVadis pour ses pratiques exceptionnelles en matière de développement durable

RAICHUR, Inde, 11 novembre 2025 /PRNewswire/ — Shilpa Pharma Lifesciences Limited, une filiale importante de Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a obtenu la prestigieuse médaille d’or d’EcoVadis, le fournisseur le plus fiable au monde d’évaluations de la durabilité des entreprises. L’entreprise a obtenu un score exceptionnel de 82/100, ce qui la place dans le… Continue reading Shilpa Pharma Lifesciences reçoit la médaille d’or EcoVadis pour ses pratiques exceptionnelles en matière de développement durable

Cytokinetics, Incorporated Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – CYTK

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The DJS Law Group  reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics ” or “the Company”) (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Cytokinetics, Incorporated Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – CYTK

KMX Investors Have Opportunity to Join CarMax, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed… Continue reading KMX Investors Have Opportunity to Join CarMax, Inc. Fraud Investigation with the Schall Law Firm

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.… Continue reading CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

FLR Investors Have Opportunity to Join Fluor Corporation Fraud Investigation With the DJS Law Group

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The DJS Law Group reminds investors that it is investigating claims against Fluor Corporation (“Fluor” or “the Company”) (NYSE: FLR) for violations of securities laws.  The investigation centers on whether the Company made false and/or misleading statements or omitted information critical to investors. On August 1, 2025, Fluor announced… Continue reading FLR Investors Have Opportunity to Join Fluor Corporation Fraud Investigation With the DJS Law Group

Stride, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – LRN

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.… Continue reading Stride, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – LRN

WPP Investors Have Opportunity to Lead WPP plc Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against WPP plc (“WPP” or “the Company”) (NYSE: WPP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange… Continue reading WPP Investors Have Opportunity to Lead WPP plc Securities Fraud Lawsuit with the Schall Law Firm

Ksaok Digital Asset Center Launches Global Green Strategy with Carbon-Neutral Data Centers

NEW YORK, Nov. 11, 2025 /PRNewswire/ — Global digital asset platform Ksaok Digital Asset Center today announced that all of its primary global data centers have officially achieved carbon-neutral operations, marking a key step in its long-term sustainability roadmap. In parallel, the company unveiled its new initiative, the Green Execution Strategy, designed to drive sustainable finance… Continue reading Ksaok Digital Asset Center Launches Global Green Strategy with Carbon-Neutral Data Centers

Marex Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MRX

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against  Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Marex Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MRX

aTyr Pharma, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.… Continue reading aTyr Pharma, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR